Compare NMAI & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NMAI | QTRX |
|---|---|---|
| Founded | 2021 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 455.9M | 160.0M |
| IPO Year | N/A | 2017 |
| Metric | NMAI | QTRX |
|---|---|---|
| Price | $13.88 | $2.66 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 97.0K | ★ 1.4M |
| Earning Date | 01-01-0001 | 05-06-2026 |
| Dividend Yield | ★ 13.14% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.64 | N/A |
| Revenue | N/A | ★ $37,632,000.00 |
| Revenue This Year | N/A | $25.49 |
| Revenue Next Year | N/A | $10.04 |
| P/E Ratio | $21.58 | ★ N/A |
| Revenue Growth | N/A | ★ 64.52 |
| 52 Week Low | $11.99 | $2.40 |
| 52 Week High | $14.38 | $8.77 |
| Indicator | NMAI | QTRX |
|---|---|---|
| Relative Strength Index (RSI) | 54.59 | 36.62 |
| Support Level | $12.64 | N/A |
| Resistance Level | $14.38 | $3.74 |
| Average True Range (ATR) | 0.21 | 0.29 |
| MACD | -0.05 | -0.00 |
| Stochastic Oscillator | 33.53 | 23.01 |
Nuveen Multi-Asset Income Fund is a closed-end management investment company. The Fund dynamically invests in a portfolio of equity and debt securities of issuers located around the world. This dynamic investment uses a risk-based framework in which any amount can be allocated to an asset-class at any time. The Fund's investment objective is to provide total return through high current income and capital appreciation.
Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services. The company sells proprietary instruments and related consumables to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies, and provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, and SP-X Imaging and Analysis System. Geographically, it operates in North America, EMEA, and the Asia Pacific.